Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: Preclinical characterization and phase I clinical trial
- Di Cosimo, S.
- Sathyanarayanan, S.
- Bendell, J.C.
- Cervantes, A.
- Stein, M.N.
- Braña, I.
- Roda, D.
- Haines, B.B.
- Zhang, T.
- Winter, C.G.
- Jha, S.
- Xu, Y.
- Frazier, J.
- Klinghoffer, R.A.
- Leighton-Swayze, A.
- Song, Y.
- Ebbinghaus, S.
- Baselga, J.
ISSN: 1557-3265, 1078-0432
Argitalpen urtea: 2015
Alea: 21
Zenbakia: 1
Orrialdeak: 49-59
Mota: Artikulua